These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8544420)
1. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Ponticelli C; Zucchelli P; Passerini P; Cesana B; Locatelli F; Pasquali S; Sasdelli M; Redaelli B; Grassi C; Pozzi C Kidney Int; 1995 Nov; 48(5):1600-4. PubMed ID: 8544420 [TBL] [Abstract][Full Text] [Related]
2. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907 [TBL] [Abstract][Full Text] [Related]
3. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605 [TBL] [Abstract][Full Text] [Related]
4. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome. Polenakovic M; Grcevska L; Dzikova S Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287 [TBL] [Abstract][Full Text] [Related]
5. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. Ponticelli C; Zucchelli P; Passerini P; Cesana B N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953 [TBL] [Abstract][Full Text] [Related]
6. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560 [TBL] [Abstract][Full Text] [Related]
15. Treatment of the nephrotic syndrome with cyclosporin A. Ponticelli C J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627 [TBL] [Abstract][Full Text] [Related]
16. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Torres A; Domínguez-Gil B; Carreño A; Hernández E; Morales E; Segura J; González E; Praga M Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104 [TBL] [Abstract][Full Text] [Related]
17. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252 [TBL] [Abstract][Full Text] [Related]
18. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Ponticelli C; Passerini P Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261 [TBL] [Abstract][Full Text] [Related]
19. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function. Mathieson PW; Turner AN; Maidment CG; Evans DJ; Rees AJ Lancet; 1988 Oct; 2(8616):869-72. PubMed ID: 2902317 [TBL] [Abstract][Full Text] [Related]
20. The advantages of immunosuppressive therapy in renal disease. Zucchelli P Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]